Kingsview Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.45M Buy
23,295
+1,760
+8% +$714K 0.16% 122
2025
Q1
$10.7M Buy
21,535
+1,238
+6% +$616K 0.2% 105
2024
Q4
$10.6M Buy
20,297
+1,694
+9% +$881K 0.21% 94
2024
Q3
$11.5M Sell
18,603
-62
-0.3% -$38.4K 0.24% 75
2024
Q2
$10.3M Buy
18,665
+533
+3% +$295K 0.24% 79
2024
Q1
$10.5M Buy
18,132
+1,128
+7% +$656K 0.26% 77
2023
Q4
$9.03M Buy
17,004
+1,591
+10% +$844K 0.27% 82
2023
Q3
$7.8M Buy
15,413
+440
+3% +$223K 0.28% 80
2023
Q2
$7.81M Sell
14,973
-1,363
-8% -$711K 0.31% 74
2023
Q1
$9.42M Buy
16,336
+3,975
+32% +$2.29M 0.4% 56
2022
Q4
$6.81M Sell
12,361
-15,690
-56% -$8.64M 0.3% 86
2022
Q3
$14.2M Buy
28,051
+10,843
+63% +$5.5M 0.67% 24
2022
Q2
$9.35M Buy
17,208
+1,055
+7% +$573K 0.45% 46
2022
Q1
$9.54M Sell
16,153
-1,117
-6% -$660K 0.42% 50
2021
Q4
$11.5M Buy
17,270
+539
+3% +$360K 0.48% 39
2021
Q3
$9.56M Buy
16,731
+662
+4% +$378K 0.45% 40
2021
Q2
$8.19M Buy
16,069
+3,047
+23% +$1.55M 0.4% 45
2021
Q1
$5.94M Buy
13,022
+5,068
+64% +$2.31M 0.34% 67
2020
Q4
$3.71M Buy
7,954
+3,552
+81% +$1.65M 0.27% 90
2020
Q3
$1.94M Buy
4,402
+10
+0.2% +$4.42K 0.17% 139
2020
Q2
$1.59M Buy
4,392
+623
+17% +$226K 0.16% 144
2020
Q1
$1.07M Buy
3,769
+912
+32% +$259K 0.14% 169
2019
Q4
$928K Buy
2,857
+1,056
+59% +$343K 0.12% 203
2019
Q3
$525K Sell
1,801
-246
-12% -$71.7K 0.08% 245
2019
Q2
$601K Sell
2,047
-1,320
-39% -$388K 0.1% 217
2019
Q1
$922K Sell
3,367
-70
-2% -$19.2K 0.14% 189
2018
Q4
$769K Sell
3,437
-150
-4% -$33.6K 0.17% 164
2018
Q3
$875K Buy
3,587
+559
+18% +$136K 0.18% 160
2018
Q2
$627K Buy
3,028
+242
+9% +$50.1K 0.15% 167
2018
Q1
$575K Buy
2,786
+671
+32% +$138K 0.14% 184
2017
Q4
$402K Buy
2,115
+261
+14% +$49.6K 0.14% 199
2017
Q3
$351K Buy
1,854
+24
+1% +$4.54K 0.15% 188
2017
Q2
$319K Buy
1,830
+51
+3% +$8.89K 0.16% 174
2017
Q1
$273K Buy
+1,779
New +$273K 0.16% 188